Off-Label Explorations: Beta Blockers Misuse among University Students in Jordan
DOI:
https://doi.org/10.71164/socialmedicine.v18i2.2025.1829Palabras clave:
Propranolol, Jordania, estudiantes universitarios, beta bloqueantesResumen
Antecedentes y objetivo. El uso no indicado de betabloqueantes entre los estudiantes universitarios para la mejora cognitiva y la
reducción del estrés ha suscitado preocupación debido a los posibles riesgos para la salud y las implicaciones para las
instituciones educativas. Este estudio tiene como objetivo explorar la prevalencia, los patrones y las percepciones del uso de
betabloqueantes entre los estudiantes universitarios en Jordania, y examinar los factores demográficos asociados y los resultados
de salud. Métodos. Se realizó una encuesta transversal en Jordania, en la que participaron estudiantes de siete universidades
públicas y privadas. La encuesta incluía preguntas demográficas e indagaciones detalladas sobre el uso de betabloqueantes. Un
total de 1.248 estudiantes participaron en el estudio. Resultados. De los participantes, el 4,29% declaró utilizar betabloqueantes,
siendo el Propranolol el más frecuente. El uso era ocasional, principalmente antes de acontecimientos académicos estresantes.
Aunque el 75,7% de los usuarios declararon haber obtenido los resultados deseados, se observó una tendencia significativa a
autoajustar las dosis sin consultar al médico. El 25,6% de los usuarios declararon efectos secundarios, y una parte sustancial
recurrió a redes informales para obtener información sobre los betabloqueantes.Conclusiones. El estudio subraya un compromiso
modesto pero significativo en el uso de betabloqueantes entre los estudiantes universitarios de Jordania con fines no médicos,
impulsado principalmente por el estrés académico. Los resultados ponen de relieve la necesidad de una mayor concienciación
sobre los riesgos del uso no supervisado, la importancia de las fuentes de información fiables y las estrategias alternativas de
gestión del estrés. Las instituciones educativas, en colaboración con los proveedores de atención sanitaria, deberían promover
mecanismos de afrontamiento más saludables y aplicar políticas para regular y supervisar la distribución de medicamentos con
receta entre los estudiantes, haciendo hincapié en la importancia del asesoramiento médico profesional
Citas
Almasdy, D., &Sharrif, A. (2011). Self-Medication Practice with Nonprescription Medication among University Students: a review of the literature. Archives of Pharmacy Practice, 2(3-2011), 95-100
Petkova V, Georgieva D, Dimitrov M, Nikolova I. Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022. Pharmaceutics 2023, Vol 15, Page 2652 [Internet]. 2023 Nov 21 [cited 2024 Mar 7];15(12):2652. Available from: https://www.mdpi.com/1999-4923/15/12/2652/htm DOI: https://doi.org/10.3390/pharmaceutics15122652
Allen HC, Garbe MC, Lees J, Aziz N, Chaaban H, Miller JL, et al. Off-Label Medication use in Children, More Common than We Think: A Systematic Review of the Literature. J Okla State Med Assoc [Internet]. 2018 Oct [cited 2024 Mar 7];111(8):776. Available from: /pmc/articles/PMC6677268/
Cavaco AM, Ribeiro J, Nørgaard LS. Exploring the use of cognitive enhancement substances among Portuguese university students. Exploratory Research in Clinical and Social Pharmacy. 2022 Mar 1; 5:100097. DOI: https://doi.org/10.1016/j.rcsop.2021.100097
Sharif S, Guirguis A, Fergus S, Schifano F. The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review. Brain Sciences 2021, Vol 11, Page 355 [Internet]. 2021 Mar 10 [cited 2024 Mar 7];11(3):355. Available from: https://www.mdpi.com/2076-3425/11/3/355/htm DOI: https://doi.org/10.3390/brainsci11030355
Abdelnasser A, Hamad R, Raju AB, Nasser AA, Mohammed H, Akondi BR. Prevalence of B-Blockers Misuse for Exam Stress and Anxiety Management among Health Professions Students in Jeddah, Saudi Arabia. Article in Journal of Ecophysiology and Occupational Health [Internet]. 2020 [cited 2024 Mar 7];20(2):1–8. Available from: https://www.researchgate.net/publication/340941423 DOI: https://doi.org/10.18311/jeoh/2020/24971
Bornand D, Reinau D, Jick SS, Meier CR. β-Blockers and the Risk of Depression: A Matched Case–Control Study. Drug Saf [Internet]. 2022 Feb 1 [cited 2024 Mar 7];45(2):181–9. Available from: https://link.springer.com/article/10.1007/s40264-021-01140-5 DOI: https://doi.org/10.1007/s40264-021-01140-5
van der Zanden TM, Smeets NJL, de Hoop‐Sommen M, Schwerzel MFT, Huang HJ, Barten LJC, et al. Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy. ClinPharmacolTher. 2022 Dec 25;112(6):1243–53. DOI: https://doi.org/10.1002/cpt.2736
Pokan R, Huonker M, Lehmann M, Dickhuth HH, Keul J. [Effect of beta blockade on hemodynamics in physical exertion]. Wien Med Wochenschr [Internet]. 1990 Apr 1 [cited 2024 Mar 7];140(6–7):178–84. Available from: https://europepmc.org/article/med/1971981
Lipworth B, Wedzicha J, Devereux G, Vestbo J, Dransfield MT. Beta-blockers in COPD: time for reappraisal. European Respiratory Journal [Internet]. 2016 Sep 1 [cited 2024 Mar 7];48(3):880–8. Available from: https://erj.ersjournals.com/content/48/3/880 DOI: https://doi.org/10.1183/13993003.01847-2015
Carpenter M, Berry H, Pelletier AL. Clinically Relevant Drug-Drug Interactions in Primary Care. AmFam Physician [Internet]. 2019 May 1 [cited 2024 Mar 7];99(9):558–64. Available from: https://www.aafp.org/pubs/afp/issues/2019/0501/p558.html
Blaufarb I, Pfeifer TM, Frishman WH. β-Blockers: Drug Interactions of Clinical Significance. Drug Saf [Internet]. 1995 Oct 27 [cited 2024 Mar 7];13(6):359–70. Available from: https://link.springer.com/article/10.2165/00002018-199513060-00005 DOI: https://doi.org/10.2165/00002018-199513060-00005
Butt, J. H., Dalsgaard, S., Torp-Pedersen, C., Køber, L., Gislason, G. H., Kruuse, C., &Fosbøl, E. L. (2017). Beta-blockers for exams identify students at high risk of psychiatric morbidity. Journal of child and adolescent psychopharmacology, 27(3), 266-273 DOI: https://doi.org/10.1089/cap.2016.0079
Carracedo-Martínez, E., Pia-Morandeira, A., &Figueiras, A. (2020). Factors associated with off-label drug use in primary care: A systematic review. Journal of Clinical Pharmacy and Therapeutics, 45(2), 270-280. doi:10.1111/jcpt.13077 DOI: https://doi.org/10.1111/jcpt.13077
Jemal, K., Hailu, D., &Mekonen, D. (2018). Self-medication practices and contributing factors among health professionals in Harar, eastern Ethiopia. PLOS ONE, 13(3), e0194318. doi:10.1371/journal.pone.0194318. DOI: https://doi.org/10.1371/journal.pone.0194318
World Health Organization. (2016). Health systems strengthening: Glossary. Geneva: WHO.
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179-211. DOI: https://doi.org/10.1016/0749-5978(91)90020-T
Armitage, C. J., & Conner, M. (2001). Efficacy of the theory of planned behaviour: A meta-analytic review. British Journal of Social Psychology, 40(4), 471-499. DOI: https://doi.org/10.1348/014466601164939
Norman, P., & Conner, M. (2005). Predicting and changing health behaviour: Future directions. In M. Conner & P. Norman (Eds.), Predicting health behaviour: Research and practice with social cognition models (pp. 324-371). Open University Press.
Webb, T. L., &Sheeran, P. (2006). Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychological Bulletin, 132(2), 249-268. DOI: https://doi.org/10.1037/0033-2909.132.2.249
Godin, G., &Kok, G. (1996). The theory of planned behavior: A review of its applications to health-related behaviors. American Journal of Health Promotion, 11(2), 87-98. DOI: https://doi.org/10.4278/0890-1171-11.2.87
Schelle KJ, Olthof BMJ, Reintjes W, Bundt C, Gusman-Vermeer J, van Mil ACCM. A survey of substance use for cognitive enhancement by university students in the Netherlands. Front SystNeurosci. 2015 Feb 17;9. DOI: https://doi.org/10.3389/fnsys.2015.00010
Alsini A, Alkhodaidi I, Alsini Y, Alsseeni S, Alkhodaidi S, Alsini E, et al. A national survey of self-prescription of beta-blockers and their relation to undiscovered anxiety among medical and pharmacological students in Saudi Arabia. Neuropsychiatr Dis Treat. 2021;17:797–807. DOI: https://doi.org/10.2147/NDT.S289833
Tounsi AA, Alnowaiser A, Alsuhibani A, Alsadhan L, Hamdan HM. Dental students’ attitude towards propranolol non‐medical use: A multi‐institutional cross‐sectional study in Riyadh, Saudi Arabia. European Journal of Dental Education. 2022 Nov 2;26(4):787–93. DOI: https://doi.org/10.1111/eje.12761
Alkhatabi R, Alowfi J, Arshad L, Khan MA. The Prevalence of Beta-Blocker Use Among Medical Students at King Saud bin Abdulaziz University for Health Sciences in Jeddah, Saudi Arabia: A Cross-Sectional Study. Cureus. 2020 Nov 11; DOI: https://doi.org/10.7759/cureus.11450
McCabe SE, Teter CJ, Boyd CJ. Medical Use, Illicit Use, and Diversion of Abusable Prescription Drugs. Journal of American College Health. 2006 Mar;54(5):269–78. DOI: https://doi.org/10.3200/JACH.54.5.269-278
Rathod P, Sharma S, Ukey U, Sonpimpale B, Ughade S, Narlawar U, et al. Prevalence, Pattern, and Reasons for Self-Medication: A Community-Based Cross-Sectional Study From Central India. Cureus. 2023 Jan;15(1): e33917. DOI: https://doi.org/10.7759/cureus.33917
Descargas
Publicado
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
